Biocon Limited (BIOCON.NS) NSE

388.35

-21.65(-5.28%)

Updated at December 04 03:30PM

Currency In INR

Valuation

Market Cap406.16B
Enterprise Value557.51B
P/E Ratio102.41
PEG Ratio4.17
Price/Sales Ratio3.15
Price/Book Ratio1.85
Enterprise/Revenue3.9
Enterprise/EBITDA18.78

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.03
Operating Margin0.21

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue152.62B
Revenue/Share128.43
Gross Profit92.44B
EBITDA31.24B
Net Income10.13B
Diluted EPS8.46

Balance Sheet

Total Cash64.69B
Total Cash/Share50.53
Total Debt165.36B
Total Debt/Equity0.62
Current Ratio1.16
Book Value Per Share258.18

Price History

52-Week Change2.28
52-Week High424.95
52-Week Low291
Moving Average 50 Days374.97
Moving Average 200 Days355.36

Statistics

Average Volume3.35M
Shares Outstanding1.34B
% Held by Institutions0.07

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield0.13
Payout Ratio0
Last Split Factor2:1
Last Split DateJune 12, 2019